Beibei Liu

999 total citations
46 papers, 711 citations indexed

About

Beibei Liu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Beibei Liu has authored 46 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Cancer Research. Recurrent topics in Beibei Liu's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (4 papers). Beibei Liu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (4 papers). Beibei Liu collaborates with scholars based in China, United States and Canada. Beibei Liu's co-authors include Xiufen Zhang, Zijian Guo, Lihua Li, Kai Fang, Meng Dong, Lei Shi, Na Yu, Xinhua Liu, Dongxue Su and Chao Yang and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Cell and Cancer Research.

In The Last Decade

Beibei Liu

44 papers receiving 705 citations

Peers

Countries citing papers authored by Beibei Liu

Since Specialization

Citations

This map shows the geographic impact of Beibei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Liu more than expected).

Fields of papers citing papers by Beibei Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beibei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Liu. The network helps show where Beibei Liu may publish in the future.

Co-authorship network of co-authors of Beibei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Beibei Liu. A scholar is included among the top collaborators of Beibei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beibei Liu. Beibei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cutting-edge technologies illuminate the neural landscape of cancer: Insights into tumor development 2025 ·Cancer Letters ·Yajing Wang, Zhao‐Jun Wang, Xinyuan Mao, (unknown), Lu Zhang, Yufei Yang, Beibei Liu, Xinxu Li, Feiyang Luo, (unknown)	1
2	Genetic Susceptibility to Causal Relationship Between Iron Metabolism Disorder Involving Immunocytes and Risk of Pneumonia and Sepsis 2025 ·Food Science & Nutrition ·(unknown), (unknown), (unknown), Zilu Wang, Beibei Liu, Ming Lu, Jiajia Zheng, Ning Shen	0
3	A novel idiotypic-based noncompetitive immunoassay based on the dissociation of immunocomplex for detection atrazine in vegetables 2025 ·Food Chemistry ·Xing Zhang, Beibei Liu, (unknown), Guangyang Liu, Linglong Chen, Junjiang Liu, Maojun Jin, (unknown), Donghui Xu, Ge Chen	2
4	Development and validation of universal PCR, basic ERA, and qPCR assays targeting the 16S-23S rRNA intergenic spacer region for Mycoplasma detection 2025 ·Microbial Pathogenesis ·(unknown), (unknown), Shiyang Li, Han Zhao, Yanna Wei, Jia Wang, Beibei Liu, (unknown), Zhixin Feng, Yanfei Yu	0
5	USP5 promotes tumor progression by stabilizing SLUG in bladder cancer 2024 ·Oncology Letters ·(unknown), Tingting Li, Beibei Liu, Bin He	1
6	Clinical phenotypes of sepsis: a narrative review 2024 ·Journal of Thoracic Disease ·Beibei Liu, (unknown)	2
7	Discovery of highly potent PARP7 inhibitors for cancer immunotherapy 2024 ·Bioorganic Chemistry ·Jieping Yang, Beibei Liu, Wenxin Yan, Xiaolin Zhao, Chenghao Wang, Qihua Zhu, Yi Zou, Yungen Xu, Hong‐Feng Gu	2
8	A PSMA PET/CT-based risk model for prediction of concordance between targeted biopsy and combined biopsy in detecting prostate cancer 2024 ·World Journal of Urology ·(unknown), Xuefeng Qiu, Beibei Liu, (unknown), Yu Yang, (unknown), Yao Fu, (unknown), (unknown), Hongqian Guo	1
9	Understanding the initiation, delivery and processing of bone cancer pain from the peripheral to the central nervous system 2023 ·Neuropharmacology ·(unknown), Beibei Liu, (unknown), Longsheng Xu, Ming Yao	9
10	Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression 2023 ·BMC Urology ·(unknown), Zhong Li, Wei Sun, (unknown), Beibei Liu, Jianmin Liu, Yuanyuan Guo	4
11	DCLK1 and its oncogenic functions: A promising therapeutic target for cancers 2023 ·Life Sciences ·Yujing Liu, Beibei Liu, Jingling Huang, Xiaolin Zhao, (unknown), Yungen Xu, Shuping Wang	5
12	CREBH promotes autophagy to ameliorate NASH by regulating Coro1a 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Xiaoling Deng, Beibei Liu, Qianqian Jiang, Guixin Li, Jiahuan Li, Keshu Xu	4
13	The crystal structure of the FERM and C-terminal domain complex of Drosophila Merlin 2021 ·Biochemical and Biophysical Research Communications ·(unknown), Beibei Liu, (unknown), Jiafu Long, Hao Zhou	5
14	Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma 2021 ·Frontiers in Cell and Developmental Biology ·Yuanyuan Guo, Beibei Liu, Yihan Liu, Wei Sun, (unknown), Shilong Mao, Li Chen	16
15	BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization 2021 ·International Immunopharmacology ·Qianqian Jiang, Qi Li, Beibei Liu, Guixin Li, (unknown), H Gaitantzi, Katja Breitkopf‐Heinlein, (unknown), Huiguo Ding, Keshu Xu	18
16	New insights into BMP9 signaling in liver diseases 2021 ·Molecular and Cellular Biochemistry ·Qianqian Jiang, Beibei Liu, Keshu Xu	12
17	Snf5 and Swi3 subcomplex formation is required for SWI/SNF complex function in yeast 2020 ·Biochemical and Biophysical Research Communications ·Hao Zhou, Guidong Chen, Chunming Dong, (unknown), (unknown), Feilong Chen, Beibei Liu, Jiafu Long	4
18	NS8593 inhibits Ca2+ permeant channels reversing mouse airway smooth muscle contraction 2019 ·Life Sciences ·Beibei Liu, Yongbo Peng, Wenjing Zhang, (unknown), Liping Chen, (unknown), Gege Wang, Yajing Liu, Jinhua Shen, Ping Zhao, Lu Xue, Meng‐Fei Yu, Weiwei Chen, Liqun Ma, Gangjian Qin, Jiapei Dai, Qinghua Liu	6
19	Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression 2016 ·Breast Cancer ·Xiufen Zhang, Yanling Fan, Beibei Liu, Xiaowei Qi, Zijian Guo, Lihua Li	17
20	FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis 2016 ·Cancer Cell ·Shan Lin, Xing Zhou, Xinhua Liu, Yue Wang, Dongxue Su, Yongqiang Hou, Na Yu, Chao Yang, Beibei Liu, Jie Gao, Yang Duan, Jianguo Yang, Wanjin Li, Jing Liang, Luyang Sun, Kexin Chen, Chenghao Xuan, Lei Shi, Yan Wang, Yongfeng Shang	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact